found that sustained activation of the MAPK/ERK signaling pathway is commonly observed in CRC patients with poor prognosis (76), and IQGAP1 activates ERK phosphorylation, further demonstrating that CRC cell growth, migration, and tumorigenesis are influenced by IQGAP1 (77). Here, MAPK1 is linked to colorectal carcinoma.